JPMA Girding for Culmination in Off-Year Re-Pricing, Tax Debates Late November-Early December: Exec

JPMA Director General Junichi Shiraishi (right), JPMA Senior Managing Director Kazuhiko Mori With debates on the planned “off-year” re-pricing and tax reform expected to culminate from late November to early December, the Japan Pharmaceutical Manufacturers Association (JPMA) will step up...read more